Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia

Journal of Pediatrics

Volumn 138, Issue 3, 2001, Pages 428-431

  Halonen, Päivi ^a   Salo, Matti K ^a   Mäkipernaa, Anne ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; DOXORUBICIN; GLUCOSE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LIVER TOXICITY; MALE; NAUSEA; PRIORITY JOURNAL;

EID: 0035089984     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.111273     Document Type: Article

References (13)

1. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of multicenter trial ALL-BFM 86
2. Treatment of acute lymphoblastic leukemia, 30 years' experience at St. Jude Children's Research Hospital
3. Acute lymphoblastic leukemia
4. Neural dysfunction during hypoglycaemia
5. Hypoglycaemia
6. Reference values of blood components related to fuel metabolism in children after an overnight fast
7. Clinical pharmacokinetics of antimetabolites
8. Hepatotoxicty of mercaptopurine
9. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems
10. Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia
11. Hepatotoxicity of 6-mercaptopurine in childhood acute lymphoblastic leukemia: Pharmacokinetic characteristics
12. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: Better in the evening
13. Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia